Director Robert Kadlec resigns from MiNK Therapeutics board for U.S. government role

MiNK Therapeutics, Inc.

Robert Kadlec, MD, resigned from the Board of Directors effective December 29, 2025.
Resignation due to acceptance of senior public service role as Assistant Secretary of War for Nuclear Deterrence and Chemical and Biological Defense Policy and Programs.
Dr. Kadlec joined the Board in October 2024; no replacement announced.
Company expressed appreciation for his service and perspective.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.